Drug Type Small molecule drug |
Synonyms RG-7906, RO-6889450 |
Target |
Mechanism TAAR1 agonists(Trace amine-associated receptor 1 agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC17H22N4O2 |
InChIKeyXHHXGKRFUPEPFM-OAHLLOKOSA-N |
CAS Registry2133417-13-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Schizoaffective disorder | Phase 2 | US | 04 Dec 2018 | |
Schizoaffective disorder | Phase 2 | JP | 04 Dec 2018 | |
Schizoaffective disorder | Phase 2 | ES | 04 Dec 2018 | |
Schizoaffective disorder | Phase 2 | UA | 04 Dec 2018 | |
Schizophrenia | Phase 2 | US | 04 Dec 2018 | |
Schizophrenia | Phase 2 | JP | 04 Dec 2018 | |
Schizophrenia | Phase 2 | ES | 04 Dec 2018 | |
Schizophrenia | Phase 2 | UA | 04 Dec 2018 |